Bio-Gene Technology

(ASX) BGT

Current PriceA$0.02

Market CapA$8.39M

Since IPO (2017)-89%

5 Year-86%

1 Year+10%

1 Month-33%

Bio-Gene Technology Financials at a Glance

Market Cap

A$8.39M

Revenue (TTM)

-A$435.00

Net Income (TTM)

-A$4.33M

EPS (TTM)

-A$0.01

P/E Ratio

-2.32

Dividend

A$0.00

Beta (Volatility)

-0.24 (Low)

Dividend

A$0.00

Beta (Volatility)

-0.24 (Low)

Price

A$0.02

Volume

573,822

Open

A$0.02

Price

A$0.02

Volume

573,822

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.02 - A$0.06

Estimated Earnings Date

Sep 1, 2026

Dividend

A$0.00

Beta (Volatility)

-0.24 (Low)

Price

A$0.02

Volume

573,822

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.02 - A$0.06

Estimated Earnings Date

Sep 1, 2026

BGT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Gene Technology

Industry

Chemicals

Sector

Materials

CEO

Tim Grogan

Website

bio-gene.com.au

Headquarters

Melbourne, VIC 3000, AU

BGT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-202%

Return on Capital

-4%

Return on Assets

-1%

Earnings Yield

-43.10%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$8.39M

Shares Outstanding

381.30M

Volume

573.82K

Avg. Volume

274.38K

Financials (TTM)

Gross Profit

-A$245.78K

Operating Income

-A$3.07M

EBITDA

-A$2.58M

Operating Cash Flow

-A$2.54M

Capital Expenditure

A$0.00

Free Cash Flow

-A$2.54M

Cash & ST Invst.

A$1.14M

Total Debt

A$51.21K

Bio-Gene Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$20.85K

+87.8%

Gross Margin

0.00%

N/A

Market Cap

A$8.39M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-A$1.40M

+7.2%

EBITDA

-A$2.77M

-80.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$1.08M

-66.5%

Total Debt

A$0.00

N/A

Accounts Receivable

A$29.28K

-94.8%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

N/A

Return on Assets

-1.33%

N/A

Return on Invested Capital

-3.73%

N/A

Free Cash Flow

-A$946.61K

+45.8%

Operating Cash Flow

-A$946.61K

+45.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IXC.AXInvex Therapeutics Ltd

IXC.AXInvex Therapeutics LtdA$0.12+31.87%

VBS.AXVectus Biosystems Limited

VBS.AXVectus Biosystems LimitedA$0.14+0.00%

IRX.AXInhaleRx Limited

IRX.AXInhaleRx LimitedA$0.03+0.00%

ACR.AXAcrux Limited

ACR.AXAcrux LimitedA$0.02-5.56%

ICR.AXIntelicare Holdings Limited

ICR.AXIntelicare Holdings LimitedA$0.02-2.13%

PER.AXPercheron Therapeutics Limited

PER.AXPercheron Therapeutics LimitedA$0.00-11.11%

BIT.AXBiotron Limited

BIT.AXBiotron LimitedA$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About BGT

What is the current price of Bio-Gene Technology?

Bio-Gene Technology is trading at A$0.02 per share.

What is the 52-week range for Bio-Gene Technology?

Over the past 52 weeks, Bio-Gene Technology has traded between A$0.02 and A$0.06.

How much debt does Bio-Gene Technology have?

As of the most recent reporting period, Bio-Gene Technology reported total debt of A$51.21K.

How much cash does Bio-Gene Technology have on hand?

Bio-Gene Technology reported A$638.34K in cash and cash equivalents in its most recent financial results.

What is Bio-Gene Technology’s dividend yield?

Bio-Gene Technology does not currently have a dividend yield.

Bio-Gene Technology

Bio-Gene Technology Financials at a Glance

BGT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bio-Gene Technology

BGT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bio-Gene Technology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BGT

What is the current price of Bio-Gene Technology?

What is the 52-week range for Bio-Gene Technology?

How much debt does Bio-Gene Technology have?

How much cash does Bio-Gene Technology have on hand?

What is Bio-Gene Technology’s dividend yield?

Premium Investing Services